Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Karema Abu-Elfotuh has a total of 152 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Awareness and adoption intent of cutaneous interstitial fluid-based biomarkers in autoimmune dermatoses among healthcare students: A descriptive cross-sectional study

    by Geetha Kandasamy, Khalid Orayj, Rayah Asiri, Asma M. Alshahrani, Asma Alzaydani, Rajalakshimi Vasudevan, Habab A. Osman, Hassabelrasoul Elfadil, Yahya Sharif, Karema Abu-Elfotuh, et al.

    Cutaneous interstitial fluid (ISF) is a minimally invasive biofluid that reflects clinically relevant biochemical and inflammatory biomarkers comparable to blood, highlighting its potential role in autoimmune and inflammatory dermatoses. However, effective clinical translation of ISF-based diagnostics depends not only on technological validation but also on the awareness and readiness of future healthcare professionals. To assess healthcare students’ knowledge, attitudes, perceptions, and willingness to adopt cutaneous ISF-based biomarker technologies for autoimmune dermatoses, and to identify factors associated with adoption intent. A cross-sectional survey was conducted among 282 healthcare students using a structured, self-administered questionnaire. Data were summarized using frequencies and percentages for categorical variables and means ± standard deviations, medians, and interquartile ranges for continuous variables. Pearson correlation and multivariable linear regression analyses were performed to examine associations and identify predictors of willingness to adopt ISF biomarkers. Among participants, 36.2% had heard of cutaneous ISF diagnostics and 27.3% could identify a specific ISF biomarker, with mean knowledge scores indicating low to moderate awareness (range: 1.57 ± 0.72 to 2.06 ± 0.83). Despite limited awareness, attitudes were favorable, with 68.8% perceiving ISF as a promising approach (mean 3.40 ± 1.05) and 73.0% expressing trust in its scientific validity (mean 3.63 ± 1.05). Willingness to adopt ISF diagnostics was high, particularly in the absence of cost constraints (73.4%, mean 3.94 ± 1.03) and with access to training (72.7%, mean 3.94 ± 1.03). Support for curriculum integration was also strong (mean scores: 3.95 ± 1.03 and 3.99 ± 1.00; Cohen d = 0.95–0.99). Knowledge and attitudes were positively correlated with adoption intent ( r = 0.42–0.51). Multivariable analysis identified attitudes (β = 0.62, P < .001) and knowledge (β = 0.18, P < .001) as significant predictors, explaining 47% of the variance ( R 2 = 0.47). A clear gap exists between limited knowledge and strong readiness to adopt ISF biomarker diagnostics among healthcare students. Despite low awareness, participants demonstrated positive attitudes, confidence in scientific validity, and willingness to pursue training and future use. These findings highlight the importance of curricular integration and targeted education to support informed adoption of ISF diagnostics in clinical practice.

  • Open Access

    Evaluation of inhaler satisfaction and medication adherence in patients with chronic obstructive pulmonary disease: A cross-sectional study

    by Geetha Kandasamy, Thangamani Subramani, Khalid Orayj, Mona Almanasef, Rayah Asiri, Asma M. Alshahrani, Rajalakshimi Vasudevan, Saleh F. Alqifari, Rehab Ahmed, Vasudevan Mani, et al.

    A cornerstone of treatment for chronic obstructive pulmonary disease (COPD) is inhalation therapy. However, incorrect use of inhalers can increase the risk of exacerbations. Adherence to inhaled medications and patient satisfaction are interrelated and play critical roles in achieving optimal symptom control. This study aimed to evaluate patient satisfaction with and adherence to inhalers among individuals with COPD. A prospective single-center observational study was conducted in a South Indian hospital, assessing inhaler adherence using the Test of Adherence to Inhalers and patient satisfaction using the Feeling of Satisfaction with Inhaler (FSI-10) questionnaire. A logistic regression model was used to identify factors associated with high inhaler satisfaction. Among 377 COPD patients (mean age = 61.8 ± 10.7 years), 57.3% reported high inhaler satisfaction (FSI-10 ≥ 43), which was associated with older age, male sex, longer disease duration, fewer current smokers, comorbidities, milder disease (global initiative for chronic obstructive lung disease I–II), dry powder inhaler use, single-inhaler therapy, long-acting beta 2 -agonist/long-acting muscarinic antagonist regimens, and fewer exacerbations (all P < .05). Good adherence (Test of Adherence to Inhalers [10-item questionnaire] = 50) was observed in 32.9%, associated with adequate inhaler knowledge, absence of forgetfulness or fear, single-inhaler use, and higher satisfaction (all P < .001). In multivariable analyses, high satisfaction was independently associated with age >60 years (Adjusted Odds Ratio [aOR] = 3.84; confidence interval [CI] = 2.12–6.97), comorbidities (aOR = 1.67; CI = 1.04–2.68), whereas multiple inhaler use (aOR = 0.62; 95% CI = 0.39–0.99) and global initiative for chronic obstructive lung disease III to IV (GOLD III to IV) (aOR = 0.48; 95% CI = 0.29–0.79) were associated with lower satisfaction.. Good adherence was independently associated with higher education (aOR = 3.12; CI = 1.94–5.02), inadequate inhaler knowledge (Adjusted aOR = 0.31; CI = 0.14–0.69), and higher FSI-10 scores (aOR per unit = 1.18; CI = 1.11–1.26). Satisfaction and adherence were moderately correlated (r = 0.46; P < .001). This study found that high inhaler satisfaction was common among patients with COPD, whereas full adherence was less frequent. Satisfaction and adherence were associated with age, disease severity, inhaler regimen complexity, education, and inhaler knowledge. The moderate positive correlation between satisfaction and adherence suggests a potential relationship that warrants further investigation in longitudinal or interventional studies.


  • Open Access

    Association between HbA1c and breast cancer risk in women with type 2 diabetes mellitus: A case-control study

    by Geetha Kandasamy, Vijayakumar Arumugam, Khalid Orayj, Tahani S. Alanazi, Rayah Asiri, Asma M. Alshahrani, Amjad Hmlan, Majed Sulaiman A Abumelha, Ibrahim Abudulaziz Mohammed Turki, Vanitha Innocent Rani, et al.

    Type 2 diabetes mellitus (T2DM) has been linked to several types of cancer, including breast cancer. Glycated hemoglobin (HbA1c) serves as an indicator of long-term blood sugar control, and elevated levels may contribute to the development of breast cancer. This study aims to evaluate the association between elevated HbA1c levels and breast cancer risk in women with T2DM attending a tertiary care hospital in South India, and to compare HbA1c levels between diabetic women with and without breast cancer. A retrospective case-control study was conducted at Kovai Medical Center from 2014 to 2016 among women with T2DM. Breast cancer was histopathologically confirmed. Data on HbA1c (P < .05. The study included 182 women with T2DM and breast cancer and 197 age-matched controls without breast cancer. Poor glycemic control (HbA1c ≥ 7.0%) was more prevalent among cases and significantly associated with breast cancer in multivariable logistic regression adjusting for age, body mass index, menopausal status, diabetes duration, and insulin use (adjusted OR = 2.98, 95% CI: 1.08–8.21, P < .0001). Additional risk factors included postmenopausal status (OR = 4.52, 95% CI: 1.36–15.00), age 50 to 59 years (OR = 8.30, 95% CI: 2.80–19.32), and insulin use (OR = 2.57, 95% CI: 1.04–3.21). Most cases were estrogen receptor and progesterone receptor negative, with 63% diagnosed at stage I. Advanced stages (II/III), triple-negative breast cancer (OR = 2.78, 95% CI: 1.05–3.65), and higher Ki-67 index (intermediate: OR = 1.91, high: OR = 3.00) were linked to more aggressive disease. In this retrospective case-control study, higher HbA1c levels (≥7.0%) were associated with breast cancer presence and more advanced tumor stages among women with T2DM, although the odds ratio for HbA1c should be interpreted cautiously. Postmenopausal status and insulin use were more common among cases, while metformin use showed a nonsignificant inverse trend. triple-negative breast cancer status and higher Ki-67 index were also more frequent in advanced disease.

  • Open Access

    Lemon Juice-Assisted Green Extraction of Strawberry Enhances Neuroprotective Phytochemicals: Insights into Alzheimer’s-Related Pathways

    by Youssef Mohamed Sharaf, Jilan A. Nazeam, Karema Abu-Elfotuh, Ayah M. H. Gowifel, Ahmed M. Atwa, Ehsan Khedre Mohamed, Ahmed M. E. Hamdan, Reema Almotairi, Amira M. Hamdan, Samir M. Osman, et al.

    Background/Objective: Alzheimer’s disease (AD) is a neurodegenerative condition characterized by oxidative stress, neuroinflammation, amyloidogenesis, and tau-related pathology. This study investigated the macronutrient and phytochemical composition of strawberry (S), lemon (L), and lemon juice-assisted strawberry (S/L) extracts and evaluated their neuroprotective efficacy relative to selenium (Se) in an aluminum chloride (AlCl3)-induced rat model of AD. Methods: Macronutrients and phenolics were quantified in S, L, and S/L, and the extracts were profiled using high-performance liquid chromatography and electrospray ionization tandem mass-spectrometry. Male Sprague–Dawley rats received AlCl3 with or without S, L, S/L, or Se, and their cognitive performance was assessed using the Morris water maze, Y-maze, and conditioned avoidance tests. Markers of oxidative status, inflammation, cholinergic function, apoptotic signaling, and Wnt3/β-catenin pathway activity were quantified in the brain tissue, and cortico-hippocampal morphology was examined. Results: The S/L extract showed the highest carbohydrate, protein, and lipid content. The total phenolic content was highest in S/L (60.46 mg gallic acid equivalents/g), followed by L (55.08) and S (44.75), with S/L also being the richest in gallic, ellagic, and chlorogenic acids. S/L attenuated AlCl3-induced cognitive deficits, restored antioxidant status, suppressed neuroinflammation, improved cholinergic indices, modulated apoptotic signaling, and downregulated amyloidogenic and NLRP3 inflammasome markers, consistent with histological evidence of neuronal preservation. Conclusions: Lemon juice-assisted extraction enhanced the macronutrient and phenolic richness and multitarget neuroprotection of strawberries. S/L co-extracts represent promising functional food–derived adjuvants for AD management and support integrative compositional–mechanistic profiling to optimize natural product–based interventions.

  • Open Access

    The potential adding therapeutic effect of pentoxifylline and/or folic acid for chronic kidney disease patients: randomized controlled trial

    by Amira Reda Muhammad Galal, Nahla Mohamed Teama, Karema Abu–Elfotuha, Ahmed D. Alatawi, Hanan Alshareef, Ahmed M. E. Hamdan, Ahmed Aljabri, Mohannad Alshibani, Zeinab AlKasaby Mahmoud Zalat

    Chronic kidney disease (CKD) is a highly prevalent, irreversible, and progressive disease associated with a high cardiovascular risk. We aimed to clinically investigate the extra-therapeutic effect of adding therapeutic doses of pentoxifylline (PTX) and/or folic acid (FA) for CKD patients to the standard care on their health-related quality. A randomized, prospective, parallel, and controlled clinical trial of CONSORT 80 patients diagnosed with CKD stages 3–5 were stratified by simple randomization into four groups (20 patient/group) and followed up for 6 months. Control group: received standard usual care therapy only; PTX group: received therapeutic dose of PTX added to standard usual care therapy; FA group: received FA added to standard usual care therapy; and PTX and FA group: received both PTX and FA added to their standard usual care therapy. The primary objective was to compare the renal function biochemical parameters for the intervention groups compared to the control group. Meanwhile, the secondary objective was to compare the incidence of readmission to hospitalization with cardiovascular events, incidence of peripheral vascular diseases and Fatigue Assessment Scale (FAS) for the intervention groups compared to the control group. This study’s research was granted authorization by the Research Ethics Committee (REC), Faculty of Medicine, Ain Shams University, No. (FMASU MS UNIV 15/2022) dated to 15/12/2022, and the Ethical Committee in the Faculty of Pharmacy (Girls), Al-Azhar University, No. (313) dated to 22/12/2022. This study was authorized by https://clinicaltrials.gov/ (NCT05284656) and the first date of registration was 16/02/2022. All patients were assigned to write an informed consent. There was a significant improvement in renal function biochemical parameters and a significant reduction in the FAS for the intervention groups compared to the control group. Our results demonstrated that administration of therapeutic doses of PTX and/or FA in CKD patients delayed the progression of advanced chronic kidney disease and has been used successfully improved their health-related quality of life.


  • Open Access

    Unlocking Therapeutic Potential of Novel Thieno-Oxazepine Hybrids as Multi-Target Inhibitors of AChE/BChE and Evaluation Against Alzheimer’s Disease: In Vivo, In Vitro, Histopathological, and Docking Studies

    by Khulood H. Oudah, Mazin A. A. Najm, Triveena M. Ramsis, Maha A. Ebrahim, Nirvana A. Gohar, Karema Abu-Elfotuh, Ehsan Khedre Mohamed, Ahmed M. E. Hamdan, Amira M. Hamdan, Reema Almotairi, et al.

    Background: Alzheimer’s disease (AD) is largely linked with oxidative stress, the accumulation of amyloid-β plaques, and hyperphosphorylated τ-protein aggregation. Alterations in dopaminergic and serotonergic neurotransmission have also been implicated in various AD-related symptoms. Methods: To explore new therapeutic agents, a series of bicyclic and tricyclic thieno-oxazepine derivatives were synthesized as potential acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitors. The resultant compounds were purified via HPLC and characterized using spectral analysis techniques. Histopathological examinations, other antioxidants, and anti-inflammatory biomarkers were evaluated, and in silico ADMET calculations were performed for synthetic hybrids. Molecular docking was utilized to validate the new drugs’ binding mechanisms. Results: The most powerful AChE inhibitors were 14 and 16, with respective values of IC50 equal to 0.39 and 0.76 µM. Derivative 15 demonstrated remarkable BChE-inhibitory efficacy, on par with tacrine, with IC50 values of 0.70 µM. Hybrids 13 and 15 showed greater selectivity towards BChE, despite substantial inhibition of AChE. Compounds 13 and 15 reduced escape latency and raised residence time, with almost equal activity to donepezil. Conclusions: According to these findings, the designed hybrids constitute multipotent lead compounds that could be used in the creation of novel anti-AD medications.


  • Open Access

    Combining vinpocetine or cocoa with levodopa, Coenzyme Q10 and vitamin B complex mitigates rotenone-induced Parkinson’s disease in rats: Impact on Nrf2/HO-1, NF-kB, AMPK/SIRT-1/Beclin-1, AKT/GSK-3β/CREB/BDNF and Apoptotic Pathways

    by Karema Abu-Elfotuh, Mohammed D. Al-Rekabi, Ashwaq N. Abbas, Alshaymaa Darwish, Ahmed M.E. Hamdan, Heba M.A. Elsanhory, Alanoud Alkhamali, Fatimah Ali Alharthi, Rehab M. Elshahat, Ahmed M. Atwa, et al.


  • Open Access

    Modulating Multiple Molecular Trajectories by Nutraceuticals and/or Physical Activity in Attention-Deficit/Hyperactivity Disorder (ADHD)-Like Behaviors in Rat Pups

    by Karema Abu-Elfotuh, Gellan Alaa Mohamed Kamel, Mazin A. A. Najm, Ahmed M. E. Hamdan, Mona T. Koullah, Rasha K. E. Fahmy, Heba Abdelnaser Aboelsoud, Manar A. Alghusn, Budor R. Albalawi, Ahmed M. Atwa, et al.

    Attention deficit/hyperactivity disorder (ADHD) is a neurodevelopmental condition affecting cognitive and social functions all over childhood. Monosodium glutamate (MSG) is a common food additive associated with ADHD-like symptoms in children. Nutraceuticals, like sesamol (SE) and astaxanthin (AST), or physical activity (PHA) were reported to possess beneficial effects on human health. Meanwhile, still their neuroprotective effect against ADHD has been poorly investigated. This study aimed to investigate the impact of SE, AST and PHA either separately or combined on ADHD-like behaviors induced by MSG in rat pups. Eighty-four male Sprague Dawley rat pups were randomly allocated into seven groups; control, MSG, (PHA + MSG), (SE + MSG), (AST + MSG), (SE + AST + MSG), and (COMB [PHA + SE + AST] + MSG) and treated for eight weeks. MSG-induced ADHD-like behavior was evaluated, via assessing behavioral outcomes; neurotransmitters’ levels; five pathway biomarkers, coupled with histopathological and immunohistochemical studies. Rats exposed to PHA or treated with SE or AST either separately or combined exhibited enhanced attention, locomotor, and cognitive abilities, compared to MSG-intoxicated group. All treatments remarkably improved MSG-induced abnormalities in neurotransmitters’ levels; biochemical markers; along with histological findings, via modulating HMGB1/RAGE/JAK-2/STAT-3, PI3K/AKT/CREB/BDNF, AMPK/SIRT-1 and PERK/CHOP pathways. Nevertheless, the combination of PHA with nutraceuticals (SE and AST) elicited more favorable effects in all measured parameters and histological findings, compared to other treated groups. In conclusion, this study revealed the superiority of the combination of nutraceuticals with PHA, over other standalone treatments, in amelioration of MSG-induced ADHD-like behaviors in rat pups, via fine-tuning of HMGB1/RAGE, PI3K/AKT/CREB/BDNF, AMPK/SIRT-1 and PERK/CHOP pathways. Graphical Abstract


  • Open Access

    Targeting Ferroptosis/Nrf2 Pathway Ameliorates AlCl3-Induced Alzheimer’s Disease in Rats: Neuroprotective Effect of Morin Hydrate, Zeolite Clinoptilolite, and Physical Plus Mental Activities

    by Karema Abu-Elfotuh, Yasmin Mahran, Walaa Bayoumie El Gazzar, Heba S. Youssef, Ahmed M. E. Hamdan, Tariq Mohammed Albalawi, Maha Alsunbul, Reem Alqahtani, Asmaa A. Mohammed

    Alzheimer’s disease (AD) is a significant health challenge in the 21st century. In spite of the approval of many new disease-modifying therapies for AD, the clinical advantages of these new treatments are less certain. Aim: This investigation was intended to determine the potential neuroprotective impact of morin hydrate (MH), zeolite clinoptilolite (ZC), and/or physical and mental activities (PhM) on an aluminum chloride (AlCl3)-induced AD rat model. Methods: Male Sprague Dawley rats were randomly allocated into seven groups. Group I was the control group. Groups II–VII were treated with AlCl3 for 5 weeks. Groups III–VII were tested for the effects of MH, ZC, and/or PhM. Biochemical, brain histopathological, and behavioral studies were performed. Results: PhM, MH, and ZC combined therapy exhibited a significant neuroprotective effect demonstrated by corrected catecholamines and tau and β-amyloid levels, as well as the antioxidant and anti-ferroptotic effects probably through Nrf2/HO-1/GPX4 and ACSL4 signaling pathways. In addition, combined therapy counteracted the inflammatory responses through modulating the TLR4/NF-κβ/NLRP3 inflammasome expression. Moreover, combined therapy groups showed the maximum improvement of both APOE4/LRP1 and Wnt3/β-catenin/GSK-3β signaling expressions. Conclusion: This research highlights the neuroprotective impact of MH and ZC plus PhM against AlCl3-induced AD via modulation of Nrf2/HO-1/GPX4, TLR4/NF-κβ/NLRP3, APOE4/LRP1, and Wnt3/β-catenin/GSK-3β signaling pathways. It is the first to point out the inclusion of ferroptosis-Nrf2/inflammasomes cross-talk in the neuroprotection mechanism of MH/ZC against the AlCl3-mediated AD model.


  • Okra seed polysaccharides mitigate neuroinflammation and cognitive impairment via modulation of Nrf2/HO-1, HMGB1/RAGE/TLR4/NF-κB, NLRP3/Caspase-1, JAK-2/STAT-3, AMPK/SIRT1/m-TOR, PI3K/AKT/CREB/BDNF/TrkB and PERK/CHOP/Bcl-2 axes

    by Jilan A. Nazeam, Ian Black, Varughese A. Mulamoottil, Nabil M. Selim, Riham A. El Shiekh, Karema Abu-Elfotuh, Ahmed M.E. Hamdan, Ayah M.H. Gowifel, Shaimaa M. Hafez, Ehsan K. Mohamed, et al.